Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

Specimen Handling 655 pembrolizumab 605 Magnetic Resonance Spectroscopy 562 Carboplatin 445 Cisplatin 396 Cyclophosphamide 394 Biopsy 378 Nivolumab 323 Paclitaxel 320 Gemcitabine 313 Radiotherapy 293 Bevacizumab 248 Dexamethasone 221 fludarabine 212 Docetaxel 201 durvalumab 193 atezolizumab 186 Oxaliplatin 186 venetoclax 182 Fluorouracil 175 Rituximab 173 Pemetrexed 172 Capecitabine 170 Radiation 166 Doxorubicin 166 Radiosurgery 158 Ipilimumab 145 Etoposide 142 Leucovorin 140 Lenalidomide 137

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

oprelvekin × 90 days × Clear all

NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting

Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡